Defiance Next Gen Altered Experience ETF
Limited financial coverage for PSY.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This fund is designed to mirror a systematically constructed index. This index evaluates the performance of companies engaged in specific, legally authorized activities, always in adherence to national laws. These activities encompass the fields of medical psychedelics, therapeutic cannabis, cannabis-derived pharmaceuticals, cannabidiol (CBD) derivatives, and ketamine.
- IPO
- 2021
- HQ
- DE, US
Get TickerSpark's AI analysis on PSY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $5.92
- 52W Low
- $5.84
- 50D MA
- $5.90
- 200D MA
- $5.90
- Beta
- 0.00
- RSI (14)
- 58
- Avg Volume
- 0
No earnings-call transcripts are available for PSY yet.
- Free Float
- 0.0%
- Shares Outstanding
- 788.28K
- Float Shares
- 0
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 10, 12 | ROBARDS KAREN P | other | 690 |
| Dec 10, 12 | KESTER W CARL | other | 100 |
| Dec 10, 12 | Harris Jerrold B | other | 161 |
| Dec 10, 12 | CAVANAGH RICHARD | other | 100 |
| Dec 10, 12 | GABBAY HENRY | other | 100 |
| Dec 10, 12 | BASSAS STEPHAN | other | 1,000 |
| Dec 5, 12 | KESTER W CARL | sell | 6,196.02 |
| Dec 5, 12 | CAVANAGH RICHARD | sell | 6,489.78 |
| Dec 5, 12 | HUBBARD ROBERT GLENN | sell | 9,682.1 |
| Dec 5, 12 | ROBARDS KAREN P | sell | 5,726.35 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PSY coverage
Recent articles, reports, and earnings notes.
No research on PSY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PSY report →Purpose Investments (PSY) Opens the Market
newsfilecorp.com · Aug 10
The Growth Potential Of Psychedelics Stocks And ETFs
seekingalpha.com · Jul 28
Diversify Your Portfolio With a New Psychedelic Drug ETF
zacks.com · Feb 2
3 Psychedelic Stocks to Play the Shroom Boom
zacks.com · Dec 22
ETFs & Innovation Go Hand In Hand
etf.com · Nov 4
Active Psychedelics ETF Launches
etf.com · Sep 16
A New Psychedelics Stocks ETF Just Launched: Here's Why It's Important
fool.com · Jun 22
3 Psychedelics Stocks Getting High Thanks to the Newly Launched PSY ETF
investorplace.com · Jun 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.